• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM Back to Search Results
Model Number MI1000 MED-EL CONCERT
Medical Device Problem Codes Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Skin Tears (2516); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/26/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device has been explanted and should be returned to the manufacturer for evaluation.When available, a device failure analysis will be submitted as a follow up report.
 
Event or Problem Description
When the user was seen a few weeks ago ((b)(6) 2023), it was noted that the tympanic membranes on both sides are retracted and on the right side the tympanic membrane is adherent to the electrode array at the fossa incudi.An extrusion of the electrode array can't be excluded.The user has been re-implanted.
 
Additional Manufacturer Narrative
Conclusion: device investigation did not reveal any device defect or damage, which has been present whilst implanted.Mechanical damages found are attributable to the removal surgery.This is expected as reimplantation surgery was performed because the electrode was exposed through the retracted tympanic membrane.No electrode extrusion could be confirmed.The retracted tympanic membrane is thought to be secondary to this patient's surgical history.This is a final report.
 
Event or Problem Description
When the user was seen a few weeks prior (b)(6) 2023), it was noted that the tympanic membranes on both sides were retracted and on the right side the tympanic membrane was adherent to the electrode array at the fossa incudi.An extrusion of the electrode array couldn't be excluded.The user has been re-implanted on (b)(6) 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM
Common Device Name
COCHLEAR IMPLANT
Manufacturer (Section D)
MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
innsbruck
AU 
Manufacturer Contact
laura simonotti
fuerstenweg 77a
innsbruck 6020
AU   6020
57788
MDR Report Key18345219
Report Number9710014-2023-001123
Device Sequence Number15003370
Product Code MCM
UDI-Device Identifier09008737062743
UDI-Public(01)09008737062743
Combination Product (Y/N)N
Initial Reporter CountryAU
PMA/510(K) Number
P000025
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 03/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date10/01/2015
Device Model NumberMI1000 MED-EL CONCERT
Was Device Available for Evaluation? Device Returned to Manufacturer
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/04/2023
Supplement Date Received by Manufacturer12/04/2023
Initial Report FDA Received Date12/18/2023
Supplement Report FDA Received Date03/12/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/01/2013
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age41 YR
Patient SexFemale
-
-